Search clinical trials for: ATG

Total 1991 results

Kafrelsheikh University

Completed

Ridge Augmentation With Simultaneous Implant Placement Using Bone Blocks With Autogenous Tooth Graft

Implant | Ridge Augmentation | Autogenous Tooth Graft

Egypt
Guangdong Provincial Hospital of Traditional Chinese...

Unknown

Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection

Gastric Cancer | Splenic Hilum Lymph Nodes Dissection | Total Gastrectomy

China
IRCCS Burlo Garofolo

Completed

Lymphocyte Count, ATG Dose and Incidence and Severity of GVHD in Pediatric Recipients of HSCT

Hematopoietic Stem Cell Transplantation

Italy
Antengene Corporation

Terminated

A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (MATCH)

Relapsed/Refractory Diffuse Large B-cell Lymphoma

China
University of Southampton

Not yet recruiting

Attentional Bias Modification Training for People With Chronic Musculoskeletal Pain (I-ABMT)

Chronic Pain

United Kingdom
Shanghai Zhongshan Hospital

Completed

Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric Cancer (CLASS02-01)

Gastric Cancer

China
Antengene Discovery Limited

Terminated

A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies (ATRIUM)

Advanced Solid Tumors | Hematological Malignancies

Australia
Shanghai Antengene Corporation Limited

Terminated

A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors (REACH)

Advanced Solid Tumors

China
Qi Zhou

Not yet recruiting

A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) (PORCH)

1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer

China
Antengene (Hangzhou) Biologics Co., Ltd.

Recruiting

A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Advanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin Lymphoma

China
The Methodist Hospital Research Institute

Unknown

Single Dose rATG for Renal Allograft Rejection

Acute (Cellular) Renal Allograft Rejection

United States
Antengene Biologics Limited

Recruiting

A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Advanced Solid Tumors | B-cell Non-Hodgkin Lymphomas

United States
Antengene Biologics Limited

Recruiting

A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors (CLINCH)

Advanced/Metastatic Solid Tumors

China, Australia
Shanghai Antengene Corporation Limited

Terminated

A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS) (HATCH)

Myelodysplastic Syndrome

China
Antengene Therapeutics Limited

Terminated

Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects

Hepatocellular Carcinoma

Korea, Republic of, Taiwan, China
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

ATG/PTCy in Haplo-PBSCT Randomized Controlled,Multi-center (ATG/PTCy)

Myeloid Tumor

China
National Institute of Blood Disease Center, Pakistan

Unknown

Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia (ATG)

Aplastic Anemia

Pakistan
Shanghai Antengene Corporation Limited

Terminated

A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH)

Advanced Solid Tumors

China
Astellas Pharma Inc

Completed

Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients

De Novo Kidney Transplant Patients

China
M.D. Anderson Cancer Center
Genzyme, a Sanofi Company

Terminated

Thymoglobulin (ATG) Dose Finding Study

Graft vs Host Disease

United States
Antengene Biologics Limited

Recruiting

A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas (PROBE)

Advanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin Lymphoma

United States, Australia
IRCCS Policlinico S. Matteo
Italian Association for Pediatric Hematology Oncology

Unknown

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation (ATG FRES)

Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer

Italy
The First Affiliated Hospital of Soochow University

Recruiting

Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation

Acute Leukemia | Hematopoietic Stem Cell Transplantation

China
Hadassah Medical Organization

Terminated

A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT

Graft Versus Host Disease | Allogeneic Haplo-Stem Cell Transplatation (SCT)

Israel
Sichuan University

Recruiting

ATG-008 Combined With Toripalimab in Advanced Solid Tumors

Advanced Solid Tumor

China
AZ-VUB

Unknown

Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients

Diabetes Mellitus, Type 1

Belgium
Nanfang Hospital of Southern Medical University

Recruiting

ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis

Hematopoietic Stem Cell Transplantation

China
Wang Xin

Not yet recruiting

Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT

GVHD

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived） (MSC-SAA)

Complications of Organ Transplant Stem Cells Umbilical Cord

China
Shanghai General Hospital, Shanghai Jiao Tong University...
The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaborators

Unknown

ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors (HSCT)

Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma

China
Neovii Biotech
University Medical Center Freiburg

Completed

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

Graft vs Host Disease

Germany
Shanghai General Hospital, Shanghai Jiao Tong University...

Unknown

Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT (ATG/PTCy)

Prophylaxis | Graft-versus-host-disease

China
M.D. Anderson Cancer Center

Completed

Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases

Lymphoma | Leukemia

United States
Tianjin First Central Hospital

Unknown

Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients (PAISPK)

Diabetes Mellitus | CKD (Chronic Kidney Disease) Stage 5T | Simultaneous Pancreas Kidney Transplantation

China
Assiut University

Unknown

Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

Severe Aplastic Anemia
Autotelicbio

Recruiting

Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes

Diabetes Mellitus, Type 2 | Essential Hypertension

Korea, Republic of
Samsung Medical Center

Recruiting

Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide

Haploidentical Hematopoietic Stem Cell Transplantation

Korea, Republic of
University of California, San Francisco

Withdrawn

Platelet Rich Fibrin and Autologous Fibrin Glue

Gingival Recession

United States
Ascentage Pharma Group Inc.
Suzhou Yasheng Pharmaceutical Co., Ltd.

Recruiting

APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors

Solid Tumor | Neuroblastoma

China
Amgen

Completed

Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

Advanced Solid Tumors

Belgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
Natural Immune Systems Inc

Completed

Nutraceutical Support of Fatigue Reduction, Improved Physical, Mental & Cognitive Function and Mitochondrial Function

Fatigue

United States
Antengene Therapeutics Limited
Bristol-Myers Squibb

Terminated

Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies (ERASER)

Solid Tumor | Hematological Malignancy

Australia
Ascentage Pharma Group Inc.
Suzhou Yasheng Pharmaceutical Co., Ltd.

Recruiting

APG-2449 in Patients With Advanced Solid Tumors

Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Malignant Pleural Mesothelioma | Advanced Solid Cancer

China
Amgen

Terminated

Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus

Cutaneous Lupus | Lupus

United States, Australia, Canada
Universitat Internacional de Catalunya

Recruiting

Comparing Tunnel Technique and CAF With CTG in Mandibular Gingival Recession Treatment

Gingival Recession Localized Moderate

Spain
Amgen

Terminated

Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (20170528)

Relapsed/Refractory Acute Myeloid Leukemia (AML)

United States, Korea, Republic of, Australia, Japan, Germany, Canada
DKMS gemeinnützige GmbH

Recruiting

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG (GRAPPA)

AML | MDS | Peripheral Blood Stem Cell Transplantation | Graft Vs Host Disease | CMML | MDS/MPN

Germany
Ascentage Pharma Group Inc.

Recruiting

A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL

Non-Hodgkins Lymphoma | T-Prolymphocytic Leukemia

United States
HanAll BioPharma Co., Ltd.
NurrOn Pharmaceuticals, Inc.

Completed

A Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants

Healthy Volunteers

Canada
Ascentage Pharma Group Inc.
Suzhou Yasheng Pharmaceutical Co., Ltd.

Terminated

APG-1252 in Patients With SCLC or Advanced Solid Tumors

Small Cell Lung Cancer and Other Solid Tumors

China

Search clinical trials for: ATG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations